Am J Transplant, Volume 16, Suppl 3 Archives - Page 27 of 180 - ATC Abstracts

2016 American Transplant Congress
Older Patients Reliably Participate in Automated Living Donor Follow Up Rather Than Avoiding This New Technology.
H. Braun, M. Parente, R. Hirose, G. Roll.
Surgery, University of California-San Francisco, San Francisco, CA.
Introduction: UCSF implemented automated living donor follow up to increase access to patients, improve communication, efficiency of data collection, and UNOS compliance. Using a modified…
2016 American Transplant Congress
Does Social Support Predict Clinical Outcomes Post-Transplantation? A Systematic Review and Meta-Analysis.
K. Ladin,¹ A. Daniels,¹ M. Osani,² R. Bannuru.²
¹Occupational Therapy, Tufts University, Medford, MA; ²Tufts Medical Center, Boston, MA.
Background: Although social support is used to determine eligibility, the relationship between social support and medication nonadherence remains unclear. We examined the predictive value of…
2016 American Transplant Congress
Exome Sequencing and HLA-Independent Prediction of Long-Term Kidney Allograft Function.
L. Mesnard,^1,3,6 T. Muthukumar,^2,9 M. Burbach,² C. Li,² H. Shang,⁴ D. Dadhania,^2,3 J. Lee,^2,3 V. Sharma,² J. Xiang,⁴ M. Carmagnat,⁵ C. Suberbielle,⁵ N. Ouali,⁶ E. Rondeau,^6,1 J. Friedewald,⁸ M. Abecassis,⁷ M. Suthanthiran,^2,9 F. Campagne.³
¹UMR1155, INSERM, Paris, France; ²Division of Nephrology and Hypertension, New York Presbyterian Hospital, New York; ³Department of Physiology and Biophysics, The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, New York, NY; ⁴Genomics Core Facility, Weill Cornell Medical College, New York, NY; ⁵Laboratoire d'histocompatibilité Hôpital Saint Louis, APHP, Paris, France; ⁶Service des Urgences Néphrologiques et Transplantation Rénale, APHP, Paris, France; ⁷Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL; ⁸Northwestern University Feinberg School of Medicine, Chicago, IL; ⁹Department of Transplantation Medicine, Weill Cornell Medical College, New York, NY.
Current strategies to improve graft outcome following kidney transplantation consider information at the HLA loci. We asked whether information outside of the HLA loci can…
2016 American Transplant Congress
Validation of the Newly Developed North America Islet Donor Scoring System in the Medium Volume Islet Transplant Center.
J. Solomina,¹ S. Matosz,¹ M. Sledzinski,² J. Golebiewska,³ O. Savaril,¹ L.-J. Wang,⁴ T. Kin,⁵ K. Golab,¹ S. Ramachandran,¹ M. Tibudan,¹ L. Schenck,¹ W. Chon,⁶ C. Thomas,⁶ P. Witkowski.¹
¹Surgery, University of Chicago, Chicago, IL; ²Surgery, Medical University of Gdansk, Gdansk, Poland; ³Internal Medicine, Medical University of Gdansk, Gdansk, Poland; ⁴Surgery, University of Illinois, Chicago, IL; ⁵Surgery, University of Alberta, Edmonton, AB, Canada; ⁶Medicine, University of Chicago, Chicago, IL.
Background.North America Islet Donor Scoring (NAIDS) system has been recently developed for selection of the optimal pancreas donor based on analysis of the results from…
2016 American Transplant Congress
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 7 Years Follow-Up.
Y. Watarai, M. Okada, K. Futamura, T. Nagai, T. Yamamoto, M. Tsujita, T. Hiramitsu, N. Goto, S. Narumi, T. Kobayashi.
Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; Kidney Transplant Surgery, Aichi Medical University, Nagoya, Aichi, Japan.
Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study from our institute…
2016 American Transplant Congress
Steroid Free Immunosuppression and Clinical Outcomes in Recipients of Deceased Donor Kidney Transplant with Positive Flow Cytometry Crossmatch.
O. Adebiyi, T. Taber, W. Goggins, D. Mishler, M. Yaqub, A. Sharfuddin.
Indiana University, Indianapolis.
Background: Positive flow cytometry crossmatch (FCXM) is considered a high immunologic risk for transplantation. Available studies reporting outcomes in positive FCXM kidney transplants were done…
2016 American Transplant Congress
Impact of Transfusion Requirements on Likelihood of Heart Transplantation After Total Artificial Heart.
J. Cook,¹ L. Kang,¹ M. Flattery,² I. Tchoukina.²
¹Internal Medicine, Virginia Commonwealth University, Richmond, VA; ²Pauley Heart Center, Virginia Commonwealth University, Richmond, VA.
Background:Total artificial heart (TAH) is used as a bridge to heart transplantation in patients with end-stage biventricular failure. Anemia requiring blood transfusions occurs following TAH…
2016 American Transplant Congress
Liver Evaluation for Heart Transplantation: Which Is Better, Noninvasive Scans or Liver Biopsy?
R. Mohan, J. Patel, M. Kittleson, D. Chang, T. Aintablian, L. Czer, F. Esmailian, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Background: Patients awaiting heart transplantation who have known liver disease from congestive hepatopathy are at increased risk for mortality post-transplantation. The evaluation of the liver…
2016 American Transplant Congress
Liver Recipient with Renal Dysfunction: Liver Only or Simultaneous Liver-Kidney Transplant?
K. Yadav, T. Pruett, R. Kandaswamy, W. Payne, L. Zhang, S. Chinnakotla.
University of Minnesota, Minneapolis, MN.
Background: The OPTN listing criteria for Simultaneous liver-kidney transplant (SLK) are not well defined. There are concerns about rising numbers of SLKs, which take kidneys…
2016 American Transplant Congress
Inferior Outcomes in Hepatitis C Virus Positive Donors to Hepatitis C Virus Negative Kidney Recipients: Analysis of National Data.
H. Fattah, L. Kang, H. Dave, D. Kumar, A. King, C. Bhati, A. Sharma, G. Gupta.
Virginia Commonwealth University, Richmond, VA.
Background: Kidney transplantation (KTxp)with HCV kidneys (HCV D+)may represent a safe resource to expand the donor pool, and to reduce waiting time in patients with…